Dr. Molly Grant Kallins, MD

Dr. Kallins practices at Mission Hospital in Asheville, North Carolina, part of HCA Healthcare.

Dr. Kallins' NPI, 1366948879, was assigned on April 3, 2018. Dr. Kallins holds North Carolina license 2022-00305.

Dr. Kallins' primary practice is Mission Hospital, at 509 Biltmore Ave, Asheville, NC 28801 in Buncombe County. The practice phone is (828) 213-1111.

Dr. Kallins' primary practice is Mission Hospital in Asheville, North Carolina, part of HCA Healthcare. Dr. Kallins is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Hospital Physician Services - Southeast Professional Corporation. Dmand AI also links Dr. Kallins to 3 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kallins practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kallins' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Kallins' licenses on file in 2 states: North Carolina and Florida.

CMS data shows 513 Medicare services from Dr. Kallins across 4 procedure codes in 2024, for 296 Medicare patients. Medicare paid $49,426 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 296 Medicare patients who saw Dr. Kallins in 2024. The largest group is 75 to 84, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kallins' median patient age at 65, with 48% women.

In 2024, Dr. Kallins wrote 161 Medicare Part D claims for 68 patients. 91% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $134 in total drug cost. In 2023, CMS named 55 claims across 3 drugs.

Dr. Kallins accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Dr. Kallins from 7 drug and device companies from 2019 to 2022. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $89.